Abstract
Omega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly $650 million to invest in drug startups. The Boston-based firm announced Monday that it has raised $647 million for its eighth fund, exceeding its original target. The total is in line with the fund Omega raised in 2021.
Key Data
-
Publication Date21 July 2025
-
Primary AuthorAllison DeAngelis
-
SourceSTATnews
-
LanguageEnglish
Click below to visit original source: